Skip Nav Destination
About the Journal
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.Read More About the Journal
Impact Factor
29.1
Featured Articles
Read the Cancer Hallmarks article collection, presented by the AACR Journals!
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker
Martin S. Taylor, et al.
Noted This Week
AbbVie announced that it will buy ImmunoGen in a deal worth about $10.1 billion, acquiring ImmunoGen’s mirvetuximab soravtansine (Elahere), a first-in-class antibody–drug conjugate (ADC) approved for the treatment of platinum-resistant ovarian cancer. Mirvetuximab soravtansine binds to folate receptor alpha (FRα), delivering the microtubule-disrupting agent DM4 to cancer cells. ImmunoGen has other ADCs in its pipeline, including IMGN151, a next-generation anti-FRα ADC for ovarian cancer that could potentially treat other tumor types, and pivekimab sunirine, an anti-CD123 ADC targeting blastic plasmacytoid dendritic cell neoplasm, a rare blood cancer.
Trending - Altmetric
Read the article titled, INX-315, a selective CDK2 inhibitor, induces cell cycle arrest and senescence in solid tumors
Last mentioned on Thursday December 7 2023
Read the article titled, Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons
Last mentioned on Thursday December 7 2023
Read the article titled, Cancer Evolution: A Multifaceted Affair
Last mentioned on Thursday December 7 2023
Read the article titled, The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
Last mentioned on Wednesday December 6 2023
The Twitter live feed is not currently active.
Keep up to date with Cancer Discovery
Advertisement